JP6847457B2 - High-pressure processed rice and food or pharmaceutical compositions containing the high-pressure processed rice - Google Patents
High-pressure processed rice and food or pharmaceutical compositions containing the high-pressure processed rice Download PDFInfo
- Publication number
- JP6847457B2 JP6847457B2 JP2018150558A JP2018150558A JP6847457B2 JP 6847457 B2 JP6847457 B2 JP 6847457B2 JP 2018150558 A JP2018150558 A JP 2018150558A JP 2018150558 A JP2018150558 A JP 2018150558A JP 6847457 B2 JP6847457 B2 JP 6847457B2
- Authority
- JP
- Japan
- Prior art keywords
- rice
- component
- rich
- paddy
- brown rice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000209094 Oryza Species 0.000 title claims description 206
- 235000007164 Oryza sativa Nutrition 0.000 title claims description 206
- 235000009566 rice Nutrition 0.000 title claims description 206
- 235000013305 food Nutrition 0.000 title claims description 17
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 6
- 235000021329 brown rice Nutrition 0.000 claims description 92
- 239000008280 blood Substances 0.000 claims description 45
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 44
- 239000008103 glucose Substances 0.000 claims description 44
- 210000004369 blood Anatomy 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 230000000694 effects Effects 0.000 claims description 24
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 23
- 235000013824 polyphenols Nutrition 0.000 claims description 23
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 18
- 238000012549 training Methods 0.000 claims description 17
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 16
- 238000003801 milling Methods 0.000 claims description 15
- 235000013312 flour Nutrition 0.000 claims description 12
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 11
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- 229960003512 nicotinic acid Drugs 0.000 claims description 9
- 235000001968 nicotinic acid Nutrition 0.000 claims description 9
- 239000011664 nicotinic acid Substances 0.000 claims description 9
- 235000019157 thiamine Nutrition 0.000 claims description 8
- 229960003495 thiamine Drugs 0.000 claims description 8
- 239000011721 thiamine Substances 0.000 claims description 8
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 7
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 6
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 6
- 238000010411 cooking Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 235000013336 milk Nutrition 0.000 claims description 6
- 239000008267 milk Substances 0.000 claims description 6
- 210000004080 milk Anatomy 0.000 claims description 6
- 229940068041 phytic acid Drugs 0.000 claims description 6
- 235000002949 phytic acid Nutrition 0.000 claims description 6
- 239000000467 phytic acid Substances 0.000 claims description 6
- 230000002708 enhancing effect Effects 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 239000012466 permeate Substances 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 4
- 229940024606 amino acid Drugs 0.000 claims description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims 1
- 238000005259 measurement Methods 0.000 description 39
- 201000010099 disease Diseases 0.000 description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 25
- 238000000034 method Methods 0.000 description 21
- 239000004615 ingredient Substances 0.000 description 19
- 208000037976 chronic inflammation Diseases 0.000 description 16
- 230000006020 chronic inflammation Effects 0.000 description 16
- 230000011987 methylation Effects 0.000 description 15
- 238000007069 methylation reaction Methods 0.000 description 15
- 235000013339 cereals Nutrition 0.000 description 14
- 238000012545 processing Methods 0.000 description 13
- 230000006870 function Effects 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 238000005498 polishing Methods 0.000 description 11
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 9
- 229920002472 Starch Polymers 0.000 description 9
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 9
- 229940114124 ferulic acid Drugs 0.000 description 9
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 9
- 235000001785 ferulic acid Nutrition 0.000 description 9
- 235000019698 starch Nutrition 0.000 description 9
- 239000008107 starch Substances 0.000 description 9
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 230000033228 biological regulation Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 6
- 238000007654 immersion Methods 0.000 description 6
- -1 sterol glycoside Chemical class 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000009534 blood test Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 238000009931 pascalization Methods 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 108700009124 Transcription Initiation Site Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910000462 iron(III) oxide hydroxide Inorganic materials 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012175 pyrosequencing Methods 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 108091029523 CpG island Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 230000007067 DNA methylation Effects 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- LSYVCAOPFHHUHM-UHFFFAOYSA-N [hydroxy-[hydroxy-[hydroxy(phosphonooxy)phosphoryl]oxyphosphoryl]oxyphosphoryl] phosphono hydrogen phosphate Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(O)=O LSYVCAOPFHHUHM-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 239000004106 carminic acid Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940080423 cochineal Drugs 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 108010004903 glycosylated serum albumin Proteins 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N inositol Chemical compound OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cereal-Derived Products (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、高圧加工技術により糠成分を糠から胚乳に浸透移行させた高圧加工米の新たな用途に関する。 The present invention relates to a new application of high-pressure processed rice in which the bran component is permeated and transferred from the bran to the endosperm by a high-pressure processing technique.
従来、米に由来する材料や成分を用いて、血糖上昇の抑制や、糖尿病の予防や改善を試みた例が知られている。具体的には、例えば、発芽玄米に含有されるステロール配糖体に着目し、発芽玄米糠由来のステロール配糖体を有効成分とする血糖値上昇抑制剤(特許文献1)や、大豆タンパク質と米糠を発酵させた発酵物をプロテアーゼで処理したものを抗糖尿病組成物として利用すること(特許文献2)が検討されている。 Conventionally, there have been known examples of attempts to suppress an increase in blood glucose and prevent or ameliorate diabetes by using materials and ingredients derived from rice. Specifically, for example, focusing on the sterol glycoside contained in germinated brown rice, a blood glucose level increase inhibitor (Patent Document 1) containing a sterol glycoside derived from germinated brown rice bran as an active ingredient, and soy protein It has been studied to use a fermented product obtained by fermenting rice bran treated with a protease as an antidiabetic composition (Patent Document 2).
また、米を味噌懸濁液に浸漬し、次いで1000気圧以上の高圧処理を施し、その後に炊飯することにより、食後血糖上昇抑制効果の期待できる米飯を提供することが試みられている(特許文献3)。
しかし、これらの文献に記載の技術は、米に由来する成分を抽出、発酵するものであるか、白米としては利用できない加工米とするものであって、いずれも食品素材としては汎用性に欠けるものであった。
Further, it has been attempted to provide cooked rice that can be expected to have an effect of suppressing postprandial blood glucose increase by immersing rice in a miso suspension, then subjecting it to a high-pressure treatment of 1000 atm or higher, and then cooking the rice (Patent Document). 3).
However, the techniques described in these documents either extract and ferment components derived from rice or make processed rice that cannot be used as white rice, and neither of them lacks versatility as a food material. It was a thing.
一方、本発明者らは、これまで、外皮付き穀物を加圧下などで水に浸漬することにより、ポリフェノール成分を増加させると共に外皮から内側に浸透移行させ、内側の可食部分にポリフェノール成分を富化することに成功した(特許文献4)。さらにこれを応用し、玄米を水に浸漬した状態で加圧することにより、糠成分を糠から胚乳に浸透移行させ、胚乳に該糠成分を富化することにより、成分富化玄米を製造し、さらに精米した成分富化精白米を提供している(特許文献5および6)。
On the other hand, the present inventors have so far increased the polyphenol component by immersing the grain with the exodermis in water under pressure or the like, and osmotically transferred the grain from the exodermis to the inside, and enriched the polyphenol component in the edible portion inside. Succeeded in conversion (Patent Document 4). Further applying this, by pressurizing the brown rice in a state of being immersed in water, the bran component is permeated and transferred from the bran to the endosperm, and the bran component is enriched in the endosperm to produce the component-enriched brown rice. Further, the rice-polished component-enriched polished rice is provided (
したがって、本発明の課題は、汎用性を備えながら、血糖値の調節機能を有する食品素材を提供することにある。 Therefore, an object of the present invention is to provide a food material having a function of regulating a blood glucose level while having versatility.
本発明者らは、前記の課題を解決するために鋭意研究する中で、意外にも、本発明者らが提供する成分富化玄米およびそれを精米した成分富化精白米が、血糖値の調節機能を有し、さらに慢性炎症を抑制すること、さらには成分富化籾が成分富化玄米と同様の成分を有することを見出し、さらに研究を進めた結果、本発明を完成するに至った。 In the diligent research to solve the above-mentioned problems, the present inventors surprisingly found that the component-enriched brown rice provided by the present inventors and the component-enriched polished rice obtained by polishing the rice have a blood glucose level. As a result of further research, it was found that it has a regulatory function, further suppresses chronic inflammation, and that the component-rich paddy has the same components as the component-rich brown rice, and as a result, the present invention has been completed. ..
すなわち、本発明は、以下の発明に関する。
[1] 高圧加工米を原料として含む、慢性炎症を抑制するため、および/または、生活習慣病を治療、予防または改善するための、食品用または医薬用組成物であって、
高圧加工米が、籾または玄米を、該籾または玄米の量に対して少なくとも50重量%の水に浸漬した状態で、加圧することにより、糠成分を糠から胚乳に浸透移行させ、胚乳に該糠成分を富化し、得られた成分富化籾または成分富化玄米、あるいは、得られた成分富化籾または成分富化玄米を精米してなる成分富化精白米である、前記組成物。
[2] 水に浸漬された籾または玄米を加温する工程をさらに含む、前記[1]に記載の組成物。
[3] 高圧加工米を製粉した米粉を原料として含む、前記[1]または[2]に記載の組成物。
[4] 糠成分が、ポリフェノール類、チアミン、ナイアシン、遊離アミノ酸、γ−アミノ酪酸およびフィチン酸を含む、前記[1]〜[3]のいずれか一項に記載の組成物。
[5] 生活習慣病が、糖尿病、高血圧または肥満である、前記[1]〜[4]のいずれか一項に記載の組成物。
[6] 中強度または高強度の負荷の運動と併用するための、前記[1]〜[5]のいずれか一項に記載の組成物。
[7] 高圧加工米を原料として含む、慢性炎症を抑制し、中強度または高強度の負荷の運動による血糖値上昇抑制効果を増強するための、食品用または医薬用組成物であって、
高圧加工米が、籾または玄米を、該籾または玄米の量に対して少なくとも50重量%の水に浸漬した状態で、加圧することにより、糠成分を糠から胚乳に浸透移行させ、胚乳に該糠成分を富化し、得られた成分富化籾または成分富化玄米、あるいは、得られた成分富化籾または成分富化玄米を精米してなる成分富化精白米である、前記組成物。
[8] 中強度または高強度の負荷の運動が、インターバル速歩トレーニングである、前記[6]または[7]に記載の組成物。
That is, the present invention relates to the following invention.
[1] A food or pharmaceutical composition containing high-pressure processed rice as a raw material for suppressing chronic inflammation and / or for treating, preventing or ameliorating lifestyle-related diseases.
The high-pressure processed rice allows the bran component to permeate and transfer from the bran to the endosperm by pressurizing the paddy or brown rice in a state of being immersed in at least 50% by weight of water with respect to the amount of the paddy or brown rice, and the rice is transferred to the endosperm. The composition, which is a component-rich paddy or component-rich brown rice obtained by enriching the bran component, or a component-rich polished rice obtained by milling the obtained component-rich paddy or component-rich brown rice.
[2] The composition according to the above [1], further comprising a step of heating paddy or brown rice soaked in water.
[3] The composition according to the above [1] or [2], which comprises rice flour obtained by milling high-pressure processed rice as a raw material.
[4] The composition according to any one of the above [1] to [3], wherein the bran component contains polyphenols, thiamine, niacin, free amino acids, γ-aminobutyric acid and phytic acid.
[5] The composition according to any one of the above [1] to [4], wherein the lifestyle-related disease is diabetes, hypertension or obesity.
[6] The composition according to any one of [1] to [5] above, for use in combination with exercise with a medium-intensity or high-intensity load.
[7] A food or pharmaceutical composition containing high-pressure processed rice as a raw material for suppressing chronic inflammation and enhancing the effect of suppressing an increase in blood glucose level due to exercise with a medium-intensity or high-intensity load.
The high-pressure processed rice allows the bran component to permeate and transfer from the bran to the endosperm by pressurizing the paddy or brown rice in a state of being immersed in at least 50% by weight of water with respect to the amount of the paddy or brown rice, and the rice is transferred to the endosperm. The composition, which is a component-rich paddy or component-rich brown rice obtained by enriching the bran component, or a component-rich polished rice obtained by milling the obtained component-rich paddy or component-rich brown rice.
[8] The composition according to the above [6] or [7], wherein the exercise with a medium-intensity or high-intensity load is interval walking training.
[9] 籾または玄米を、該籾または玄米の量に対して少なくとも50重量%の水に浸漬した状態で、加圧することにより、糠成分を糠から胚乳に浸透移行させ、胚乳に該糠成分を富化し、得られた成分富化籾または成分富化玄米、あるいは、得られた成分富化籾または成分富化玄米を精米してなる成分富化精白米である高圧加工米であって、慢性炎症を抑制するため、および/または、生活習慣病を治療、予防または改善するための、前記高圧加工米。
[10] 前記[9]に記載の高圧加工米を炊飯してなる、慢性炎症を抑制するため、および/または、生活習慣病を治療、予防または改善するための、米飯。
[11] 慢性炎症を抑制し、中強度または高強度の負荷の運動による血糖値上昇抑制効果を増強するための高圧加工米であって、籾または玄米を、該籾または玄米の量に対して少なくとも50重量%の水に浸漬した状態で、加圧することにより、糠成分を糠から胚乳に浸透移行させ、胚乳に該糠成分を富化し、得られた成分富化籾または成分富化玄米、あるいは、得られた成分富化籾または成分富化玄米を精米してなる成分富化精白米である、前記高圧加工米。
[12] 中強度または高強度の負荷の運動が、インターバル速歩トレーニングである、前記[11]に記載の高圧加工米。
[13] 前記[11]または[12]に記載の高圧加工米を炊飯してなる、慢性炎症を抑制し、中強度または高強度の負荷の運動による血糖値上昇抑制効果を増強するための、米飯。
[9] By pressurizing the paddy or brown rice in a state of being immersed in at least 50% by weight of water with respect to the amount of the paddy or brown rice, the bran component is permeated and transferred from the bran to the germ milk, and the bran component is transferred to the germ milk. High-pressure processed rice, which is a component-rich paddy or component-rich brown rice obtained by enriching the rice, or a component-rich polished rice obtained by milling the obtained component-rich paddy or component-rich brown rice. The high-pressure processed rice for suppressing chronic inflammation and / or for treating, preventing or ameliorating lifestyle-related diseases.
[10] Cooked rice obtained by cooking the high-pressure processed rice according to the above [9], for suppressing chronic inflammation and / or for treating, preventing or ameliorating lifestyle-related diseases.
[11] High-pressure processed rice for suppressing chronic inflammation and enhancing the effect of suppressing increase in blood glucose level due to exercise with medium-intensity or high-intensity load, and rice or brown rice is added to the amount of the paddy or brown rice. By pressurizing while immersed in at least 50% by weight of water, the bran component is permeated and transferred from the bran to the germ milk, and the bran component is enriched in the germ milk. Alternatively, the high-pressure processed rice, which is a component-rich polished rice obtained by polishing the obtained component-rich paddy or component-rich brown rice.
[12] The high-pressure processed rice according to the above [11], wherein the exercise with a medium-intensity or high-intensity load is interval walking training.
[13] The high-pressure processed rice according to the above [11] or [12] is cooked to suppress chronic inflammation and enhance the effect of suppressing the increase in blood glucose level by exercising with a medium-intensity or high-intensity load. Rice.
また本発明は、一態様として、以下の発明に関する。
[A] 玄米を、該玄米の量に対して少なくとも50重量%の水に浸漬した状態で、加圧することにより、糠成分を糠から胚乳に浸透移行させ、胚乳に該糠成分を富化し、得られた成分富化玄米を精米してなる高圧加工米であって、生活習慣病を予防または改善するための、前記高圧加工米。
[B] 糠成分が、ポリフェノール類、チアミン、ナイアシン、遊離アミノ酸、γ−アミノ酪酸およびフィチン酸を含む、前記[A]に記載の高圧加工米。
[C] 生活習慣病が、糖尿病、高血圧または肥満である、前記[A]または[B]に記載の高圧加工米。
[D] 前記[A]〜[C]のいずれか一項に記載の高圧加工米を炊飯してなる、米飯。
[E] 保存用容器に収容された、前記[D]に記載の米飯。
[F] インターバル速歩トレーニングと併用するための、前記[D]または[E]に記載の米飯。
Further, the present invention relates to the following invention as one aspect.
[A] By pressurizing the brown rice in a state of being immersed in at least 50% by weight of water with respect to the amount of the brown rice, the bran component is permeated and transferred from the bran to the endosperm, and the bran component is enriched in the endosperm. High-pressure processed rice obtained by milling the obtained component-enriched brown rice, which is used to prevent or improve lifestyle-related diseases.
[B] The high-pressure processed rice according to the above [A], wherein the bran component contains polyphenols, thiamine, niacin, free amino acids, γ-aminobutyric acid and phytic acid.
[C] The high-pressure processed rice according to the above [A] or [B], wherein the lifestyle-related disease is diabetes, hypertension or obesity.
[D] Cooked rice obtained by cooking the high-pressure processed rice according to any one of the above [A] to [C].
[E] The cooked rice according to [D] above, which is contained in a storage container.
[F] The cooked rice according to the above [D] or [E] for use in combination with the interval walking training.
本発明に係る高圧加工米によれば、生活習慣病の治療、予防または改善効果が得られる。とくに、運動処方を実施してもなお、生活習慣病の改善効果が頭打ちになっている対象者に対し、生活習慣病の改善効果が得られる。本発明に係る高圧加工米は、持続的に摂取することにより、生活習慣病の改善の中でも、食事後の血糖上昇が抑制され、血糖調節機能の改善において、とくに優れている。 According to the high-pressure processed rice according to the present invention, the effect of treating, preventing or improving lifestyle-related diseases can be obtained. In particular, the improvement effect of lifestyle-related diseases can be obtained for the subjects whose improvement effect of lifestyle-related diseases has reached a plateau even after the exercise prescription is implemented. By continuously ingesting the high-pressure processed rice according to the present invention, the increase in blood glucose after meals is suppressed among the improvement of lifestyle-related diseases, and the high-pressure processed rice is particularly excellent in improving the blood glucose regulation function.
さらに本発明に係る高圧加工米は、炎症促進性遺伝子であるNFκB2遺伝子のメチル化を亢進し、慢性炎症を抑制することができる。慢性炎症は、種々の疾患と関連しており、例えば、脂肪細胞への影響がインシュリン抵抗性およびII型糖尿病に、免疫細胞への影響が動脈硬化に、脳細胞への影響が認知症に、全身性サイトカインの上昇を介して癌に関連することが知られている(非特許文献1)。本発明に係る高圧加工米は、生活習慣病の改善に止まらず、他の慢性炎症に関連する疾患に対しても改善効果が期待できる。 Further, the high-pressure processed rice according to the present invention can enhance the methylation of the NFκB2 gene, which is an inflammation-promoting gene, and suppress chronic inflammation. Chronic inflammation is associated with a variety of diseases, for example, the effects on adipocytes on insulin resistance and type II diabetes, the effects on immune cells on arteriosclerosis, and the effects on brain cells on dementia. It is known to be associated with cancer through an increase in systemic cytokines (Non-Patent Document 1). The high-pressure processed rice according to the present invention can be expected to have an improving effect not only on improving lifestyle-related diseases but also on other diseases related to chronic inflammation.
本発明に係る高圧加工米の奏する生活習慣病の改善効果は、中強度または高強度の負荷の運動、とくに緩急運動の1種であるインターバル速歩トレーニングと並行して行うことにより、さらに優れている。5ヵ月間のインターバル速歩トレーニングによって、体力(筋力)が向上し、高血圧、高血糖、肥満の症状が改善し、炎症促進性遺伝子であるNFκB2遺伝子のメチル化がおき、体内の炎症反応が抑制されるところ(非特許文献2)、これらの改善効果は、約6ヵ月以降頭打ちになることが課題であったが(非特許文献3)、本発明に係る高圧加工米を摂取することにより、インターバル速歩トレーニングの改善効果をさらに促進することができる。 The effect of improving lifestyle-related diseases produced by the high-pressure processed rice according to the present invention is further excellent when it is performed in parallel with medium-intensity or high-intensity load exercise, particularly interval fast walking training which is a kind of slow and fast exercise. .. Interval walking training for 5 months improves physical strength (muscle strength), improves symptoms of hypertension, hyperglycemia, and obesity, methylates the NFκB2 gene, which is an pro-inflammatory gene, and suppresses the inflammatory reaction in the body. (Non-Patent Document 2), the problem was that these improvement effects peaked after about 6 months (Non-Patent Document 3), but by ingesting the hypertensive processed rice according to the present invention, the interval was increased. The improvement effect of fast walking training can be further promoted.
玄米や発芽玄米は、炊飯準備の困難さ、食味や食感の低下、消化性の悪さにより持続的な摂取が容易ではない場合があるが、本発明に係る高圧加工米のうち成分富化精白米は、これらの問題を生じることなく、炊飯により良食味の白米として摂取が容易であることから、生活習慣病の治療、予防または改善に効果的である。 Brown rice and germinated brown rice may not be easily ingested continuously due to difficulty in preparing cooked rice, deterioration of taste and texture, and poor digestibility. White rice is effective in treating, preventing or ameliorating lifestyle-related diseases because it is easy to ingest as good-tasting white rice by cooking rice without causing these problems.
本発明に係る高圧加工米は、成分富化籾、成分富化玄米、および、成分富化籾または成分富化玄米から精米した成分富化精白米を含む。
以下、成分富化精白米の精白前の成分富化玄米を中心に説明するが、成分富化籾についても同様である。
The high-pressure processed rice according to the present invention includes component-rich paddy, component-rich brown rice, and component-rich polished rice milled from component-rich paddy or component-rich brown rice.
Hereinafter, the description will be focused on the component-rich brown rice before polishing of the component-rich polished rice, but the same applies to the component-rich paddy.
本発明に係る成分富化玄米は、ポリフェノール、ビタミン類等任意の糠成分を通常の米と比較して高濃度に含有していることに加えて、浸漬等によって成分が富化された穀類と比較して、粒割れの割合が低く、精米歩留まりが向上している。また、炊飯した際の食感が従来の成分富化玄米と比較して改良されており、これによって、炊飯した際の食感が改良されている。 The component-enriched brown rice according to the present invention contains any bran component such as polyphenols and vitamins in a higher concentration than that of ordinary rice, and in addition, it is a cereal whose component is enriched by immersion or the like. In comparison, the rate of grain cracking is low and the rice milling yield is improved. In addition, the texture when cooked rice is improved as compared with the conventional component-rich brown rice, which improves the texture when cooked rice.
本発明において、その加工過程において、所定量の水に浸漬することによって、製造された成分富化玄米の精米歩留まりを向上させることが可能になる。水の量は、玄米の場合、一般的な玄米の吸水量である30重量%以上が望ましく、50重量%以上であると更に望ましい。籾の場合は、50重量%以上であることが望ましい。 In the present invention, it is possible to improve the rice polishing yield of the produced component-rich brown rice by immersing it in a predetermined amount of water in the processing process. In the case of brown rice, the amount of water is preferably 30% by weight or more, which is the water absorption amount of general brown rice, and more preferably 50% by weight or more. In the case of paddy, it is desirable that it is 50% by weight or more.
本発明において、浸漬に使用する水には、所望の成分を添加することが可能である。これにより、前記所望の成分が製造された成分富化玄米に移行し、富化させることが可能になる。ここで、「所望の成分」の用語は、本来種皮に含まれる成分(例えば、ビタミンB1、ビタミンB3、γ―オリザノール等)と、本来種皮には含まれず、加工時に添加することにより富化される成分、例えば、コチニールやアントシアニン等の色素とのいずれも含む意味で使用する。従って、本発明の製造方法においては、種皮に含有されている成分のみでなく、加工処理の段階で適宜添加された成分も富化された成分富化玄米を製造することが可能である。 In the present invention, a desired component can be added to the water used for immersion. As a result, the desired component can be transferred to the produced component-enriched brown rice and enriched. Here, the term "desired ingredient" is rich by adding ingredients originally contained in the seed coat (for example, vitamin B 1 , vitamin B 3 , γ-oryzanol, etc.) and ingredients not originally contained in the seed coat and added at the time of processing. It is used in the sense that it includes any of the components to be converted, for example, pigments such as cochineal and anthocyanin. Therefore, in the production method of the present invention, it is possible to produce component-enriched brown rice enriched not only with the components contained in the seed coat but also with components appropriately added at the stage of processing.
本発明において、その加工過程において、浸漬は、密閉容器に封入した状態で行われることが望ましい。これにより、浸漬に使用する水の量を正確に制御することが可能となり、かつ、加工時に玄米全体に均一に静水圧を加えることが可能になる。 In the present invention, in the processing process, it is desirable that the immersion is performed in a state of being sealed in a closed container. As a result, it is possible to accurately control the amount of water used for immersion, and it is possible to uniformly apply hydrostatic pressure to the entire brown rice during processing.
本発明において、その加工過程において、所定の圧力で加圧することによって、成分富化玄米のでんぷん損傷率を0〜15%に抑えることが可能となる。これにより、炊飯した際のでんぷんの糊化、流出が抑えられ、食感を向上させることが可能となる。また同時に、精米時の精米歩留まりを向上させることが可能となる。この際の圧力は、0.2MPa以上が望ましく、100MPa以上であるとさらに望ましい。 In the present invention, the starch damage rate of the component-enriched brown rice can be suppressed to 0 to 15% by pressurizing at a predetermined pressure in the processing process. As a result, gelatinization and outflow of starch when rice is cooked can be suppressed, and the texture can be improved. At the same time, it becomes possible to improve the rice polishing yield at the time of rice polishing. The pressure at this time is preferably 0.2 MPa or more, and more preferably 100 MPa or more.
本発明において、その加工過程において、所定の時間加圧することが望ましい。これにより、精米歩留まりを向上させ、同時により多くの成分を富化させることが可能になる。この時間の長さは、3時間以上であることが望ましく、作業効率等を勘案すると、12時間程度が望ましい。 In the present invention, it is desirable to pressurize for a predetermined time in the processing process. This makes it possible to improve the rice milling yield and at the same time enrich more components. The length of this time is preferably 3 hours or more, and is preferably about 12 hours in consideration of work efficiency and the like.
本発明において、その加工過程において、所定の温度で加温することが望ましい。これにより、製造された成分富化玄米に富化する成分の量を増加させることが可能になる。加温時の温度は、所望の効果を得るために20℃以上が望ましく、40℃以上であると更に望ましい。温度の上限は、一般的に玄米のでんぷんが糊化する65℃以下である必要があり、60℃以下であると更に望ましい。加温は、浸漬と同時にあるいは順次行われ、浸漬時に加温する場合、加工される玄米に上記温度が加温される程度となるよう、水温を調整する必要がある。 In the present invention, it is desirable to heat at a predetermined temperature in the processing process. This makes it possible to increase the amount of ingredients enriched in the produced ingredient-enriched brown rice. The temperature at the time of heating is preferably 20 ° C. or higher, and more preferably 40 ° C. or higher in order to obtain a desired effect. The upper limit of the temperature generally needs to be 65 ° C. or lower at which brown rice starch is gelatinized, and more preferably 60 ° C. or lower. The heating is performed at the same time as the immersion or sequentially, and when the heating is performed at the time of immersion, it is necessary to adjust the water temperature so that the above temperature is heated to the brown rice to be processed.
本発明において、濃度が向上している糠成分としては、ポリフェノール類が挙げられる。向上する程度は、処理の際の圧力、温度等の条件によって異なり、通常は、総ポリフェノール量として2倍から4倍程度であるが、成分や条件によっては、10倍程度まで向上する。例えば、フェルラ酸は未処理時の5倍から6倍まで向上し、p−クマル酸では、未処理時の10倍まで向上する。また、γ−アミノ酪酸については、未処理の精白米からは検出されない成分であって、本発明に係る成分富化玄米を製造する過程において、はじめて定量される成分である。また、本発明に係る成分富化玄米では、上記に示す成分以外のビタミン類等の成分が富化されていても良く、これらの成分には、種皮に含有されている成分のみでなく、加工処理の段階で適宜添加された成分も含まれる。つまり、本発明に係る成分富化玄米では、加工時に浸漬する水に所望の成分を添加することで、種皮由来ではない成分を胚乳部分に浸透移行することが可能である。 In the present invention, examples of the bran component having an improved concentration include polyphenols. The degree of improvement varies depending on the conditions such as pressure and temperature at the time of treatment, and is usually about 2 to 4 times as the total amount of polyphenols, but it is improved up to about 10 times depending on the components and conditions. For example, ferulic acid improves from 5 to 6 times as much as untreated, and p-coumaric acid improves up to 10 times as much as untreated. Further, γ-aminobutyric acid is a component that is not detected in untreated polished rice and is a component that is quantified for the first time in the process of producing the component-enriched brown rice according to the present invention. Further, in the component-enriched brown rice according to the present invention, components such as vitamins other than the components shown above may be enriched, and these components include not only the components contained in the seed coat but also processed components. Ingredients appropriately added at the stage of treatment are also included. That is, in the component-enriched brown rice according to the present invention, by adding a desired component to the water soaked during processing, it is possible to permeate and transfer the component not derived from the seed coat to the endosperm portion.
本発明において、成分富化玄米の表面や内部のでんぷんは、電子顕微鏡で観察すると、その外形から角がとれており、角丸の状態、あるいは形状が略球状または略偏球状となっている。このため、本発明に係る成分富化玄米は、口に入れた際の食感が良く、また、製粉して米粉として使用した際にも、手触りや食感が良好である。 In the present invention, the starch on the surface and inside of the component-enriched brown rice has rounded corners or a substantially spherical or substantially oblate spherical shape when observed with an electron microscope. Therefore, the component-enriched brown rice according to the present invention has a good texture when put in the mouth, and also has a good texture and texture when milled and used as rice flour.
本発明の高圧加工米(成分富化籾、成分富化玄米および成分富化精白米)の原料として使用する米は、とくに限定はされず、日本および外国で食用として用いられる米であれば、いずれも適用可能である。本発明により製造された高圧加工米は、食用米として好適に使用することが可能である。また、本発明により製造された成分富化精白米を製粉することにより、成分富化米粉として、好適に使用することが可能である。さらに、本発明により製造された成分富化米粉は、その用途として、成分が富化された加工食品として、好適に使用することが可能である。 The rice used as a raw material for the high-pressure processed rice (component-rich paddy, component-rich brown rice, and component-rich polished rice) of the present invention is not particularly limited as long as it is rice used for food in Japan and abroad. Both are applicable. The high-pressure processed rice produced according to the present invention can be suitably used as edible rice. Further, by milling the component-enriched polished rice produced according to the present invention, it can be suitably used as component-enriched rice flour. Furthermore, the ingredient-rich rice flour produced according to the present invention can be suitably used as a processed food enriched in ingredients for its use.
本発明の高圧加工米は、生活習慣病を治療、予防または改善するための、食品用または医薬用組成物の原料として用いることができる。また本発明の高圧加工米は、生活習慣病を治療、予防または改善するための食材として、とくに主食として摂取することができる。
ここで生活習慣病とは、生活習慣が発症原因に深く関与していると考えられている疾患の総称であり、糖尿病、高血圧または肥満などを包含するものである。本発明の高圧加工米は、とくに血糖調節機能に優れ、とくに、糖尿病や肥満の治療、予防または改善に優れている。
The high-pressure processed rice of the present invention can be used as a raw material for food or pharmaceutical compositions for treating, preventing or ameliorating lifestyle-related diseases. Further, the high-pressure processed rice of the present invention can be ingested as a food material for treating, preventing or ameliorating lifestyle-related diseases, particularly as a staple food.
Here, lifestyle-related diseases are a general term for diseases in which lifestyle-related diseases are considered to be deeply involved in the cause of onset, and include diabetes, hypertension, obesity, and the like. The high-pressure processed rice of the present invention is particularly excellent in blood glucose regulation function, and particularly excellent in treatment, prevention or improvement of diabetes and obesity.
本発明の高圧加工米は、慢性炎症を抑制するための、食品用または医薬用組成物の原料として用いることができる。また本発明の高圧加工米は、慢性炎症を抑制するための食材として、とくに主食として摂取することができる。 The high-pressure processed rice of the present invention can be used as a raw material for food or pharmaceutical compositions for suppressing chronic inflammation. Further, the high-pressure processed rice of the present invention can be ingested as a food material for suppressing chronic inflammation, particularly as a staple food.
さらに本発明の高圧加工米は、慢性炎症を抑制し、中強度または高強度の負荷の運動による血糖値上昇抑制効果を増強するために用いることができる。
ここで中強度または高強度の負荷の運動とは、最大体力の70%以上のややきつい運動のことで、血糖値上昇抑制効果が期待できる運動などが含まれ、例えば、速い歩行、ジョギング、水泳、エアロビクスなどの他、ウェイト・トレーニングや水中歩行など運動療法に取り入れられている各種の運動を含み得る。本発明の高圧加工米を併用する中強度または高強度の負荷の運動とは、前記の各種の運動の他、ゆっくり歩きと速歩を交互に繰り返す緩急ウォーキングなどの緩急運動が含まれ、とくにインターバル速歩トレーニングとの併用が好ましい。
Further, the high-pressure processed rice of the present invention can be used to suppress chronic inflammation and enhance the effect of suppressing an increase in blood glucose level due to exercise with a medium-intensity or high-intensity load.
Here, medium-intensity or high-intensity load exercise is a slightly hard exercise of 70% or more of the maximum physical strength, and includes exercise that can be expected to suppress an increase in blood glucose level. For example, fast walking, jogging, and swimming. , Aerobics, etc., may include various exercises incorporated into exercise therapy such as weight training and underwater walking. The medium-intensity or high-intensity load exercise in which the high-intensity processed rice of the present invention is used in combination includes the above-mentioned various exercises as well as slow-moving exercises such as slow-moving walking in which slow walking and fast walking are alternately repeated, and particularly interval fast walking. It is preferable to use it in combination with training.
本発明の高圧加工米は、慢性炎症を抑制することができることから、例えば、インシュリン抵抗性およびII型糖尿病、動脈硬化、認知症、癌に対して、改善効果が期待できる。 Since the high-pressure processed rice of the present invention can suppress chronic inflammation, it can be expected to have an improving effect on, for example, insulin resistance and type II diabetes, arteriosclerosis, dementia, and cancer.
本発明の高圧加工米は、一般の精白米と同様に製品化が可能である。例えば、精白米を袋詰めした製品や、精白米を炊飯し、米飯として製品とすることができる。とくに米飯とする場合は、レトルトパックなどの保存容器に収容されていてもよい。 The high-pressure processed rice of the present invention can be commercialized in the same manner as general polished rice. For example, a product in which polished rice is packed in a bag or a product in which polished rice is cooked can be used as cooked rice. In particular, when cooked rice is used, it may be stored in a storage container such as a retort pack.
また本発明の高圧加工米は、加工食品、機能性食品などの食材としても用いることができ、一般の精白米が利用される態様において利用することができる。
また、飼料用として用いることも可能である。
以下、実施例を示して、本発明をさらに具体的に説明するが、本発明の範囲は、これら実施例の記載に何ら限定されるものではない。
Further, the high-pressure processed rice of the present invention can also be used as a food material for processed foods, functional foods and the like, and can be used in a mode in which general polished rice is used.
It can also be used for feed.
Hereinafter, the present invention will be described in more detail with reference to Examples, but the scope of the present invention is not limited to the description of these Examples.
[実験例1 成分富化玄米および成分富化精白米の製造]
原料となる米は、信州大学農学部の圃場で収穫された、2015年度または2016年度産コシヒカリ玄米を用いた。玄米は実験に使用するまで、ポリエチレン袋に入れて密封し、冷蔵庫に貯蔵した。加圧装置は、株式会社東洋高圧製の高圧処理装置「まるごとエキス(登録商標)」を使用した。加圧処理時の圧力保持と、温度調整は、前記高圧処理装置の制御装置を未補正で使用した。処理玄米の乾燥は、送風乾燥器(VTRL-1000-2Tいすゞ製作所製)を用いて実施した。
[Experimental Example 1 Production of component-rich brown rice and component-rich polished rice]
As the raw material rice, Koshihikari brown rice produced in 2015 or 2016, which was harvested in the field of the Faculty of Agriculture, Shinshu University, was used. The brown rice was placed in a polyethylene bag, sealed, and stored in a refrigerator until it was used in the experiment. As the pressurizing device, a high-pressure processing device "Marugoto Extract (registered trademark)" manufactured by Toyo Koatsu Co., Ltd. was used. For pressure retention and temperature adjustment during the pressurization process, the control device of the high pressure process device was used uncorrected. The treated brown rice was dried using a blower dryer (VTRL-1000-2T manufactured by Isuzu Seisakusho).
玄米3kgと、所定量の蒸留水をポリエチレン袋に入れ、袋の中の空気が残らないよう減圧に保ちながら密閉し、シーラーを用いて封入した。その後、直ちに55℃に設定しておいた高圧処理装置に入れ、温度を保ちながら、100MPa下で6時間処理を行った。処理後の玄米を成分富化玄米試料とし、この玄米を乾燥後精米したものを、本実施例における成分富化精白米(高圧加工米)の試料とした。 3 kg of brown rice and a predetermined amount of distilled water were placed in a polyethylene bag, sealed while keeping the pressure reduced so that no air remained in the bag, and sealed using a sealer. Immediately after that, the mixture was placed in a high-pressure treatment apparatus set at 55 ° C., and the treatment was carried out under 100 MPa for 6 hours while maintaining the temperature. The treated brown rice was used as a component-rich brown rice sample, and the dried brown rice was used as a sample of the component-rich polished rice (high-pressure processed rice) in this example.
[実験例2 コントロール米の製造]
実験例1と同様のコシヒカリ玄米をコントロール玄米とした。また、これを精米して、未処理の精白米を製造し、これをコントロール精白米の試料とした。
[Experimental example 2 Production of control rice]
The same Koshihikari brown rice as in Experimental Example 1 was used as the control brown rice. Further, this was milled to produce untreated polished rice, which was used as a sample of control polished rice.
(精米歩留まりの測定)
実験例1と同様に製造した成分富化玄米について、加工時に浸漬する水量による精米歩留まりの変化を測定した。加工した玄米を乾燥後、家庭用精米機(RSKM5B 株式会社サタケ製)により精米した。図1は、添加水量と、玄米の吸水率、精米歩留まりの関係を示すグラフを示す。この結果から、添加水量が増加するに従って精米歩留まりも向上し、添加水量が50重量%以上となると、精米歩留まりが80%を超えることが認められた。
(Measurement of rice milling yield)
For the component-enriched brown rice produced in the same manner as in Experimental Example 1, the change in rice polishing yield due to the amount of water immersed during processing was measured. The processed brown rice was dried and then milled with a household rice mill (RSKM5B, manufactured by Satake Corporation). FIG. 1 shows a graph showing the relationship between the amount of added water, the water absorption rate of brown rice, and the rice polishing yield. From this result, it was confirmed that the rice polishing yield improved as the amount of added water increased, and when the amount of added water was 50% by weight or more, the rice polishing yield exceeded 80%.
(総ポリフェノール量の測定)
本発明に係る成分富化精白米の可溶性総ポリフェノール量およびフェノール酸量を定量した。米試料中の総ポリフェノール量はChandrikaらの方法を参考に、一部改変したFolin-Ciocalteu法で測定した。米に含まれるポリフェノール類の主要な成分はフェルラ酸であることから、総ポリフェノール量をフェルラ酸当量で表した。
(Measurement of total polyphenol amount)
The total amount of soluble polyphenols and the amount of phenolic acid in the component-enriched polished rice according to the present invention were quantified. The total amount of polyphenols in the rice sample was measured by the partially modified Folin-Ciocalteu method with reference to the method of Chandrika et al. Since the main component of polyphenols contained in rice is ferulic acid, the total amount of polyphenols is expressed as ferulic acid equivalent.
フェルラ酸100mgに50%アセトン水を加えて100mlに定容し、1mg/mlのフェルラ酸標準溶液を調製した。この標準溶液に純水を加えて適宜希釈し、複数の濃度のフェルラ酸標準溶液を調製した。各フェルラ酸標準溶液0.5mlに純水を加えた後、フォリン・チオカルト−フェノール試薬1.0ml、20%炭酸ナトリウム水溶液(w/v)1.0ml、純水4.5mlを加えて反応させた。その後、遠心分離(5,000×g,5分間)し、得られた上清の725nmにおける吸光度を分光光度計(UV-1800 UV/VIS Spectrophotometer 株式会社島津製作所製)を用いて測定し、吸光度の値とフェルラ酸濃度から検量線を作成した。 50% acetone water was added to 100 mg of ferulic acid, and the volume was adjusted to 100 ml to prepare a 1 mg / ml ferulic acid standard solution. Pure water was added to this standard solution and diluted appropriately to prepare a ferulic acid standard solution having a plurality of concentrations. After adding pure water to 0.5 ml of each ferulic acid standard solution, 1.0 ml of folin-thiocalto-phenol reagent, 1.0 ml of 20% sodium carbonate aqueous solution (w / v), and 4.5 ml of pure water are added and reacted. It was. Then, it was centrifuged (5,000 × g, 5 minutes), and the absorbance of the obtained supernatant at 725 nm was measured using a spectrophotometer (UV-1800 UV / VIS Spectrophotometer, manufactured by Shimadzu Corporation), and the absorbance was measured. A calibration curve was prepared from the value of and the ferric acid concentration.
成分富化精白米、およびコントロール精白米について、総ポリフェノール量を上記と同様の方法で吸光度から定量した。測定は各処理試料溶液につき2回ずつ行い、各試料溶液の測定値はフェルラ酸を標準物質として作成した検量線に代入して、可溶性の総ポリフェノール量を算出した。実験では、総ポリフェノール量は、精白米、玄米および米糠100g当たりのフェルラ酸当量(FAE mg/精白米100g)で表した。 For the component-enriched polished rice and the control polished rice, the total amount of polyphenols was quantified from the absorbance by the same method as described above. The measurement was performed twice for each treated sample solution, and the measured value of each sample solution was substituted into a calibration curve prepared using ferulic acid as a standard substance to calculate the total amount of soluble polyphenols. In the experiment, the total amount of polyphenols was expressed as ferulic acid equivalent (FAE mg / 100 g of polished rice) per 100 g of polished rice, brown rice and rice bran.
表1は、加工時に加温する温度ごとの成分富化玄米およびコントロール玄米それぞれの精米歩留まり、成分富化玄米およびコントロール玄米をそれぞれ精米した、成分富化精白米およびコントロール精白米100g中に含まれるフェルラ酸当量を表した表である。表中、成分富化玄米と書かれた項目では、付加する圧力と温度を変更してそれぞれの数値を示している。表から、加温する温度を上げるに従って、精米歩留まりと総ポリフェノール量が向上していることが認められた。特に、55℃、100MPaで処理した成分富化精白米においては、総ポリフェノール量が86.0mg/100gと、コントロール米の31.0mg/100gと比較して、約3倍の量のポリフェノールを含有することが認められた。また、本発明に係る成分富化玄米を製造する際には、付加する圧力、および温度が高いほど、ポリフェノール量が増加し、同時に、精米歩留まりが向上することが認められた。 Table 1 is contained in 100 g of component-enriched polished rice and control-polished rice obtained by polishing the component-rich brown rice and control brown rice, respectively, and the component-enriched brown rice and control brown rice, respectively, for each temperature heated during processing. It is a table showing the ferric acid equivalent. In the table, the item labeled "Ingredient-enriched brown rice" shows the respective values by changing the applied pressure and temperature. From the table, it was found that the rice milling yield and the total amount of polyphenols improved as the heating temperature was increased. In particular, the component-enriched polished rice treated at 55 ° C. and 100 MPa contains 86.0 mg / 100 g of total polyphenols, which is about three times the amount of 31.0 mg / 100 g of control rice. Was allowed to do. Further, in the production of the component-enriched brown rice according to the present invention, it was found that the higher the applied pressure and temperature, the higher the amount of polyphenols, and at the same time, the higher the rice milling yield.
(チアミンの測定)
本発明に係る成分富化精白米に富化された成分として、チアミンの定量を行った。測定は、HPLC法を用いて行い、チアミン塩酸塩として定量した。図2は、成分富化精白米およびコントロール精白米それぞれ100g中に含まれるチアミンの量を表したグラフである。グラフ中、未処理とされるデータがコントロール米を示し、水/温/圧とされるデータが成分富化精白米を示している。この結果から、成分富化精白米において、0.22mg/100gと、コントロール米の0.09mg/100gと比較して、約2.4倍の量のチアミンを含有することが認められた。
(Measurement of thiamine)
As a component enriched in the component-enriched polished rice according to the present invention, thiamine was quantified. The measurement was performed using the HPLC method and quantified as thiamine hydrochloride. FIG. 2 is a graph showing the amount of thiamine contained in 100 g of each of component-enriched polished rice and control-polished rice. In the graph, the untreated data indicates the control rice, and the water / temperature / pressure data indicates the component-rich polished rice. From this result, it was confirmed that the component-enriched polished rice contained 0.22 mg / 100 g, which was about 2.4 times the amount of thiamine as compared with 0.09 mg / 100 g of the control rice.
(ナイアシンの測定)
成分富化玄米に富化された成分として、ナイアシンの定量を行った。測定は、Lactobacillus plantarum ATCC8014菌株を使用した微生物定量法を用いて行った。なお、この際、ニコチン酸相当量、トリプトファンは考慮していない。図3は、成分富化精白米およびコントロール精白米それぞれ100g中に含まれるナイアシンの量を表したグラフである。グラフ中、未処理とされるデータがコントロール精白米を示し、水/温/圧とされるデータが成分富化精白米を示している。この結果から、成分富化精白米において、4.32mg/100gと、コントロール米の1.78mg/100gと比較して、約2.4倍の量のナイアシンを含有することが認められた。
(Measurement of niacin)
Ingredient-enriched niacin was quantified as an ingredient enriched in brown rice. The measurement was performed using a microbial quantification method using the Lactobacillus plantarum ATCC8014 strain. At this time, the amount equivalent to nicotinic acid and tryptophan are not taken into consideration. FIG. 3 is a graph showing the amount of niacin contained in 100 g of each of component-enriched polished rice and control-polished rice. In the graph, the untreated data indicates the controlled polished rice, and the water / temperature / pressure data indicates the component-enriched polished rice. From this result, it was confirmed that the component-enriched polished rice contained 4.32 mg / 100 g, which was about 2.4 times the amount of niacin as compared with 1.78 mg / 100 g of the control rice.
(γ−アミノ酪酸の測定)
成分富化玄米に富化された成分として、γ−アミノ酪酸の定量を行った。測定は、アミノ酸自動分析法を用いて行った。その結果、コントロール精白米では、含有量が検出限界以下であったため、定量できなかったのに対し、成分富化精白米では、16mg/100g検出され、成分富化精白米では、コントロール精白米よりも多くのγ−アミノ酪酸を含有することが認められた。
(Measurement of γ-aminobutyric acid)
Ingredient-enriched γ-aminobutyric acid was quantified as an ingredient enriched in brown rice. The measurement was performed using an automatic amino acid analysis method. As a result, in the control-polished rice, the content was below the detection limit, so that it could not be quantified. In contrast, in the component-enriched polished rice, 16 mg / 100 g was detected, and in the component-enriched polished rice, it was higher than the control-polished rice. Was also found to contain a large amount of γ-aminobutyric acid.
(フィチン酸の測定)
成分富化玄米に富化された成分として、フィチン酸の定量を行った。測定は、バナドモリブデン酸吸光光度法を用いて行い、メソイノシットヘキサリン酸として定量した。その結果、コントロール精白米では、155mg/100gであったのに対し、成分富化精白米では、183mg/100g検出され、成分富化精白米では、コントロール精白米よりも多くのフィチン酸を含有することが認められた。
(Measurement of phytic acid)
Ingredient-enriched Phytic acid was quantified as an ingredient enriched in brown rice. The measurement was performed using the vanadomolybdate absorptiometry and quantified as mesoinosit hexaphosphoric acid. As a result, it was 155 mg / 100 g in the controlled polished rice, whereas 183 mg / 100 g was detected in the component-rich polished rice, and the component-rich polished rice contained more phytic acid than the controlled polished rice. Was recognized.
(米粉試料の物性の分析)
成分富化玄米および成分富化米粉の物性を評価するため、米粉の平均粒径と、でんぷん損傷率を測定した。粒度の測定には、レーザー回折・散乱式粒度分析計(MT3000LOW-DRY 日機装株式会社製)を使用し、乾式法による粒度分布計測値から、平均粒径を求めた。粒度分布の測定は、各試料3回ずつ行い、平均値(μm)を算出した。また、でんぷん損傷率の測定には、STARCH DAMAGE KIT(K-SDAM Megazyme社製)を使用した。結果を表2に示す。
(Analysis of physical properties of rice flour sample)
In order to evaluate the physical properties of the component-rich brown rice and the component-rich rice flour, the average particle size of the rice flour and the starch damage rate were measured. A laser diffraction / scattering type particle size analyzer (manufactured by MT3000LOW-DRY Nikkiso Co., Ltd.) was used to measure the particle size, and the average particle size was obtained from the particle size distribution measurement values by the dry method. The particle size distribution was measured three times for each sample, and the average value (μm) was calculated. The STARC DAMAGE KIT (manufactured by K-SDAM Megazyme) was used to measure the starch damage rate. The results are shown in Table 2.
表2は、成分富化米粉およびコントロール米粉の平均粒径およびでんぷん損傷率を測定した結果を示す。表から、成分富化米粉の平均粒径とでんぷん損傷率が、いずれもコントロール米粉の値よりも低いことが認められた。これは、成分富化玄米の製造を行う加工時に、加圧をする工程があるため、これにより米の密度が高まったことによる。米の密度が高いこと、およびでんぷん損傷率が低いことは、炊飯時のでんぷんの糊化、溶出を抑制し、食味を向上させるのに寄与している。 Table 2 shows the results of measuring the average particle size and starch damage rate of the component-enriched rice flour and the control rice flour. From the table, it was found that the average particle size and the starch damage rate of the component-enriched rice flour were both lower than the values of the control rice flour. This is because there is a process of pressurizing the rice during the processing to produce the ingredient-rich brown rice, which increases the density of the rice. The high density of rice and the low starch damage rate contribute to suppressing gelatinization and elution of starch during rice cooking and improving the taste.
[実験例3 高圧加工米摂取による生活習慣病の治療、予防または改善効果]
実験例1と同様に製造した成分富化精白米(高圧加工米)の生活習慣病の治療、予防または改善効果を検証した。
<方法>
6か月以上インターバル速歩(IWT)トレーニングを継続しているにもかかわらず、血糖と血圧が高止まりしている、すなわち、空腹時血糖値>110mg/dlまたはHbA1c>6.2%、かつ、SBP>135またはDBP>85mmHgである30人(80歳未満の男女)を被験者とした。被験者を、高圧加工米群(n=15)と通常米群(白米群;n=15)とに無作為に割り付けた。
[Experimental example 3 Treatment, prevention or improvement effect of lifestyle-related diseases by ingesting high-pressure processed rice]
The effect of treating, preventing or improving lifestyle-related diseases of the component-enriched polished rice (high-pressure processed rice) produced in the same manner as in Experimental Example 1 was verified.
<Method>
Despite continuing interval walking (IWT) training for more than 6 months, blood glucose and blood pressure remain high, that is, fasting blood glucose> 110 mg / dl or HbA1c> 6.2%, and The subjects were 30 subjects (men and women under 80 years old) having SBP> 135 or DBP> 85 mmHg. Subjects were randomly assigned to a high-pressure processed rice group (n = 15) and a normal rice group (white rice group; n = 15).
なお、インターバル速歩(IWT)とは、息があがるように“さっさか”歩く速歩き(さっさか歩き)と、呼吸を整えてリフレッシュするように“ゆっくり”歩くゆっくり歩き(ゆっくり歩き)を交互に数分間ずつ(例えば、3分間ずつ)繰り返し行うトレーニング方法をいう(NPO法人熟年体育大学リサーチセンター;URL: http://www.jtrc.or.jp/interval/)。
被験者は、週4回以上(1回速歩時間15分以上)を目標に実施した。
In addition, interval fast walking (IWT) alternates between fast walking (quick walking) that walks "quickly" so that you can breathe, and slow walking (slow walking) that walks "slowly" so that you can adjust your breathing and refresh. A training method that is repeated for several minutes (for example, three minutes each) (NPO Research Center for Mature Physical Education; URL: http://www.jtrc.or.jp/interval/).
The subjects performed the test four times or more a week (one trot time of 15 minutes or more).
両群ともIWTをさらに4ヶ月間(2016年12月〜2017年4月)実施させた(IWT+試験米摂取期間)。その間、高圧加工米群は、朝・夕の食事にレトルトパックした高圧加工米を1食当たり175g(0.5合)摂取させ、通常米群は、朝・夕の食事にレトルトパックした通常米を1食当たり175g(0.5合)摂取させた。
介入前後に、6日間の血糖値の連続測定(酵素電極)を実施し、5日目にすべての被験者に同じ食事(統制食)を摂取させた。また、以下の測定項目についても測定を行った。
Both groups underwent IWT for an additional 4 months (December 2016-April 2017) (IWT + test rice intake period). During that time, the high-pressure processed rice group ingested 175 g (0.5 go) of high-pressure processed rice retort-packed for morning and evening meals, and the normal rice group retort-packed normal rice for morning and evening meals. Was ingested at 175 g (0.5 go) per meal.
Before and after the intervention, continuous measurement of blood glucose level (enzyme electrode) was performed for 6 days, and on the 5th day, all subjects were allowed to eat the same diet (controlled diet). The following measurement items were also measured.
測定項目
・体力測定:
身長、体重、BMI、体脂肪率、腹囲周囲長、伸展筋力、屈曲筋力、最大運動量、
・血液検査:
赤血球、白血球、ヘマトクリット、ヘモグロビン、血小板数、アルブミン、総コレステロール、TG、LDL−C、HDL−C、尿酸、高感度CRP
・血糖調節機能:
血液検査(空腹時血糖、HbA1c、グリコアルブミン、空腹時インスリン濃度)、CGM(持続血糖測定)6日間、SMBG(自己血糖測定)6日間
・循環調節機能:
最高血圧(SBP)、最低血圧(DBP)、PWV(脈波伝播速度)、ABI(足関節上腕血圧比)、安静時心拍数
Measurement items ・ Physical fitness measurement:
Height, weight, BMI, body fat percentage, abdominal circumference, extension muscle strength, flexion muscle strength, maximum exercise amount,
·Blood test:
Red blood cells, white blood cells, hematocrit, hemoglobin, platelet count, albumin, total cholesterol, TG, LDL-C, HDL-C, uric acid, high-sensitivity CRP
・ Blood sugar regulation function:
Blood test (fasting blood glucose, HbA1c, glycoalbumin, fasting insulin concentration), CGM (continuous blood glucose measurement) 6 days, SMBG (self-blood glucose measurement) 6 days ・ Circulation regulation function:
Maximum blood pressure (SBP), minimum blood pressure (DBP), PWV (pulse wave velocity), ABI (ankle-brachial blood pressure ratio), resting heart rate
(持続血糖測定・自己血糖測定のプロトコール)
持続血糖測定は、腹部にセンサーを留置し、グルコース濃度を5分間隔で測定した。また、センサーで測定するグルコース濃度の較正のため、1日4回の自己血糖測定を行った。プロトコールの概要を図4に示す。
(循環調節機能測定の方法)
仰向けになり、血圧計カフ、心電図電極、心音マイクを装着し、測定した。
(Protocol for continuous blood glucose measurement / self-blood glucose measurement)
For continuous blood glucose measurement, a sensor was placed in the abdomen and the glucose concentration was measured at 5-minute intervals. In addition, self-blood glucose measurement was performed four times a day to calibrate the glucose concentration measured by the sensor. The outline of the protocol is shown in FIG.
(Method of measuring circulatory regulation function)
He lay on his back, attached a sphygmomanometer cuff, electrocardiogram electrodes, and a heart sound microphone, and measured.
以下、各測定結果を示すが、IWT+試験米摂取期間の前の測定結果を「Pre」、後の測定結果を「Post」として示す。
体力測定の結果を表3に示す。
The results of the physical fitness test are shown in Table 3.
血液検査の結果を表4に示す。
血糖調節機能の結果を表5に示す。
循環調節機能の結果を表6に示す。
持続血糖測定・自己血糖測定の測定結果を図5〜9に示す。
6日間の朝食前の血糖値は、高圧加工米群でのみ介入後に低下した(P=0.04)(図5、6)。また、5日目の朝食開始から3時間の血糖値の上昇も、同群でのみ介入後に低下した(P=0.02)。すべての被験者が介入の前後で同じ食事を摂取したにもかかわらず、食後血糖(BG)の増加は、介入後の高圧加工米群においてのみ抑制された(図8)。介入後の高圧加工米群においてのみJ−indexが有意に低下した(図9)。
The measurement results of continuous blood glucose measurement and self-blood glucose measurement are shown in FIGS. 5 to 9.
The 6-day pre-breakfast blood glucose level decreased after the intervention only in the high-pressure processed rice group (P = 0.04) (FIGS. 5 and 6). In addition, the increase in
結果から、生活習慣病患者において、本発明に係る高圧加工米の摂取により血糖調節能を改善することが示された。とくに、インターバル速歩(IWT)トレーニングと並行して持続的に行うことにより、より高い効果が得られることが明らかになった。 From the results, it was shown that ingestion of the high-pressure processed rice according to the present invention improves the blood glucose regulation ability in patients with lifestyle-related diseases. In particular, it was clarified that a higher effect can be obtained by continuously performing the interval walking (IWT) training in parallel.
[実験例4 高圧加工米摂取によるNFκB2遺伝子のメチル化]
インターバル速歩トレーニングと並行して高圧加工米を摂取した場合において、NFκB2遺伝子のメチル化に及ぼす影響を調査した。
実験例3と同様に得た血液サンプルからPLC DNA Isol. Kit Large Volume((株)ロシュ・ダイアグノスティックス、東京)を用いてDNAを抽出し、パイロシークエンス(PyroMarkQ24ID, QIAGEN、Germany)により、介入前後におけるNFκB2遺伝子のメチル化率を測定した。PCRおよびシークエンスプライマーは、PyroMark Assay Design 2.0 software (QIAGEN、Germany)により作成され、全ての実験操作は推奨されているプロトコールに沿って行った。NFκB2遺伝子のプロモーター領域(-1281 to -1018 upstream of the transcription start site)はPCRにより増幅した。
使用したプライマーを表7に示す。
We investigated the effect of NFκB2 gene methylation on ingestion of high-pressure processed rice in parallel with interval fast walking training.
DNA was extracted from the blood sample obtained in the same manner as in Experimental Example 3 using PLC DNA Isol. Kit Large Volume (Roche Diagnostics Co., Ltd., Tokyo), and by pyrosequence (PyroMark Q24ID, QIAGEN, Germany). The methylation rate of the NFκB2 gene was measured before and after the intervention. PCR and sequence primers were prepared by PyroMark Assay Design 2.0 software (QIAGEN, Germany) and all experimental procedures were performed according to the recommended protocol. The promoter region of the NFκB2 gene (-1281 to -1018 upstream of the transcription start site) was amplified by PCR.
The primers used are shown in Table 7.
哺乳類において、DNAメチル化はCpGアイランドに存在するシトシンにおいて、優先的に起こる。それゆえ、NFκB2のターゲット領域は、
5’- AAAGGGCGCGAGGCGTGACGCACGGAAACGTCA - 3’(配列番号4)
(-1238 to -1206 upstream of the transcription start site)
とした。
In mammals, DNA methylation occurs preferentially in cytosine present on CpG islands. Therefore, the target region of NFκB2 is
5'- AAAGGGCGCGAGGCGTGACGCACGGAAACGTCA --3'(SEQ ID NO: 4)
(-1238 to -1206 upstream of the transcription start site)
And said.
EpiTect Buisulfite Kit(QIAGEN、Germany)を用いて、ゲノムDNAにバイサルファイト処理を行った。バイサルファイト処理後のDNAを精製し、Nano Dropを用いて、DNA濃度を10ng/μlに調整した。バイサルファイト処理済DNAはPyroMark PCR Master Mix kit(QIAGEN、Germany)を用いて、5’末端がビオチン化されたプライマーでPCR増幅した。ビオチン化されたPCR産物は、ストレプトアビジンビーズ(GE Healthcare、Sweden)の上に固定化し、DNA鎖はDenaturation Solution(QIAGEN、Germany)を用いて分離した。それを洗浄後、PyroMark Q24 Vacuum Workstationによって中和し、シークエンスプライマーは固定化した鎖にアニーリングした。 Genomic DNA was bisulfite-treated using the EpiTect Buisulfite Kit (QIAGEN, Germany). The DNA after the bisulfite treatment was purified, and the DNA concentration was adjusted to 10 ng / μl using Nano Drop. The bisulfite-treated DNA was PCR-amplified using a PyroMark PCR Master Mix kit (QIAGEN, Germany) with a primer having a biotinylated 5'end. The biotinylated PCR product was immobilized on streptavidin beads (GE Healthcare, Sweden) and the DNA strands were separated using the Denaturation Solution (QIAGEN, Germany). After cleaning it, it was neutralized by PyroMark Q24 Vacuum Workstation and sequence primers were annealed to the immobilized strands.
パイロシークエンスにより得られた波形(パイログラム)から、PyroMark Q24 system (QIAGEN, Germany)のPyroMark Q24 softwareを用いて、波形のピーク(高さ)からターゲット領域におけるメチル化シトシンと非メチル化シトシンの割合を求めることでNFκB2のメチル化率を算出した。Reportタブから、「CpG analysis report」を決定し小数第二位までを有効数字として解析に使用した。本発明ではNFκB2遺伝子のプロモーター領域における6か所(sites 1〜6)のメチル化変異(非メチル化シトシンからメチル化シトシンへの変異)部位を解析した。なお、この6か所のメチル化変異部位は、先行研究において、インターバル速歩によりメチル化が亢進した部位である(非特許文献2)。この際、同一被験者のトレーニング前後のサンプルは、一度にPCR・シークエンスを行い、測定条件の違いによって生じるメチル化率の誤差が介入前後の変化量に影響するリスクを極力抑えるようにした。解析は、sites 1〜6のメチル化率を平均して行った。
From the waveform (pyrogram) obtained by the pyrosequence, using the PyroMark Q24 software of the PyroMark Q24 system (QIAGEN, Germany), the ratio of methylated cytosine and unmethylated cytosine in the target region from the peak (height) of the waveform. The methylation rate of NFκB2 was calculated by determining. From the Report tab, "CpG analysis report" was determined and the second decimal place was used for analysis as significant figures. In the present invention, 6 sites (
図10に介入前後に採取した血液サンプルより抽出したDNAを対象に、パイロシークエンス法により測定したNFκB2遺伝子のsites 1〜6のメチル化率の平均値について、通常米群、高圧加工米群それぞれ、15名の平均値と標準誤差で示した。図10中、Aは介入前(白抜き)、介入後(黒塗り)のぞれぞれのメチル化率を示し、Bは介入による変化量を示す。測定には、両群ともに介入前後のメチル化率に有意差を認めなかった(P>0.1)。しかし、各siteにおける介入前後の変化量の平均値を群間比較したところ、高圧加工米群では、通常米群と比較して、NFκB2遺伝子のメチル化が亢進した(P=0.045)。
In FIG. 10, the mean values of the methylation rates of
[実験例5 成分富化籾の製造]
原料となる米は、信州大学農学部の圃場で収穫された、2016年度または2017年度産コシヒカリの籾を用いた。
籾3kgと、所定量の蒸留水をポリエチレン袋に入れ、袋の中の空気が残らないよう減圧に保ちながら密閉し、シーラーを用いて封入した。その後、直ちに所定の温度(57℃、60℃または62℃)に設定しておいた高圧処理装置に入れ、温度を保ちながら、所定の圧力下(100MPa〜150MPa)で所定の時間(2時間〜8時間)処理を行った。処理後の籾を成分富化籾試料とした。
[Experimental Example 5 Production of component-rich paddy]
As the raw material rice, Koshihikari paddy from 2016 or 2017, which was harvested in the field of the Faculty of Agriculture, Shinshu University, was used.
3 kg of paddy and a predetermined amount of distilled water were placed in a polyethylene bag, sealed while keeping the pressure reduced so that no air remained in the bag, and sealed using a sealer. Immediately after that, it is placed in a high-pressure processing device set to a predetermined temperature (57 ° C, 60 ° C or 62 ° C), and while maintaining the temperature, under a predetermined pressure (100 MPa to 150 MPa) for a predetermined time (2 hours to 8 hours) processing was performed. The treated paddy was used as a component-enriched paddy sample.
[実験例6 成分富化籾の外観]
(a)成分富化籾の外観(1)
実験例5と同様に製造した成分富化籾(57℃、120MPa、2、4または6時間、水分添加量70%)および未処理籾について、夫々1000粒を採取し、整粒、胴割粒および砕粒を計数した。結果を表8に示す。なお、表中、「その他」は半粉状質粒などを示す。
(A) Appearance of component-rich paddy (1)
For the component-enriched paddy (57 ° C., 120 MPa, 2, 4 or 6 hours,
(b)成分富化籾の外観(2)
実験例5と同様に製造した成分富化籾(57℃または60℃、120MPa、4時間、水分添加量40%〜70%)、成分富化玄米(57℃、120MPa、4時間、水分添加量56%)および未処理籾について、夫々1000粒を採取し、整粒、胴割粒および砕粒を計数した。結果を表9に示す。なお、表中、「その他」は半粉状質粒などを示す。
Component-rich paddy (57 ° C or 60 ° C, 120 MPa, 4 hours,
表8および表9に示すとおり、成分富化籾は、未処理籾や成分富化玄米に比べて、整粒数が増加し、精白米としての利用に優れた外観品質を有することが示されるものであった。 As shown in Tables 8 and 9, it is shown that the component-rich paddy has an increased number of sized grains and has excellent appearance quality for use as polished rice as compared with untreated paddy and component-rich brown rice. It was a thing.
[実験例7 高圧加工籾から精米した高圧加工精白米の外観]
実験例5と同様に製造した成分富化籾(57℃、120MPa、6時間、水分添加量70%)、成分富化玄米(57℃、120MPa、6時間、水分添加量56%)および未処理籾の夫々を精米し、夫々1000粒を採取し、整粒、胴割粒および砕粒を計数した。結果を表10に示す。なお、表中、「その他」は半粉状質粒などを示す。
Ingredient-enriched paddy (57 ° C., 120 MPa, 6 hours,
表10に示すとおり、成分富化籾は、未処理籾や成分富化玄米に比べて、整粒数が増加し、精白米としての利用に優れた外観品質を有することが示されるものであった。 As shown in Table 10, the component-rich paddy has an increased number of sized grains as compared with untreated paddy and component-rich brown rice, and is shown to have excellent appearance quality for use as polished rice. It was.
[実験例8 高圧加工籾の機能性成分]
実験例5と同様に製造した成分富化籾から精米した高圧加工精白米(57℃、120MPa、4時間、水分添加量40%〜70%)、成分富化玄米(57℃、100MPa、6時間、水分添加量56%)、未処理玄米および未処理白米について、夫々、総ポリフェノール量およびGABA量を測定した。結果を図11に示す。
なお、総ポリフェノール量およびGABA量の測定は、実験例2と同様の方法で行った。
[Experimental Example 8 Functional component of high-pressure processed paddy]
High-pressure processed polished rice (57 ° C, 120 MPa, 4 hours,
The total amount of polyphenols and the amount of GABA were measured by the same method as in Experimental Example 2.
図11に示すとおり、成分富化籾から精米した高圧加工精白米は、成分富化玄米に比べて総ポリフェノール量は7割程度であるが、未処理白米に比べて1.5倍程度の増加が認められるものであり、GABA量は成分富化玄米に比べて1.1倍程度、未処理白米に比べて5倍以上の増加が認められるものであった。 As shown in FIG. 11, the total amount of polyphenols in the high-pressure processed polished rice milled from the component-rich paddy is about 70% of that of the component-rich brown rice, but it is about 1.5 times higher than that of the untreated white rice. The amount of GABA was increased by about 1.1 times as compared with the component-enriched brown rice and more than 5 times as compared with the untreated white rice.
実験例8の結果から、成分富化籾は、成分富化玄米および成分富化精白米と同程度の成分を含んでおり、これらと同様に生活習慣病を治療、予防または改善するため、および/または、慢性炎症を抑制するための食材として摂取することができる。 From the results of Experimental Example 8, the component-rich paddy contains the same amount of components as the component-rich brown rice and the component-rich polished rice, and similarly for treating, preventing or ameliorating lifestyle-related diseases, and / Or, it can be ingested as a food material for suppressing chronic inflammation.
本発明の高圧加工米は、生活習慣病を治療、予防または改善するため、および/または、慢性炎症を抑制するための食材として、とくに一般の精白米と同様に、主食として容易に持続的に摂取することができる。 The high-pressure processed rice of the present invention can be easily and continuously used as a food material for treating, preventing or ameliorating lifestyle-related diseases and / or suppressing chronic inflammation, and as a staple food, particularly like general polished rice. Can be ingested.
Claims (7)
高圧加工米が、籾または玄米を、該籾または玄米の量に対して少なくとも50重量%の水に浸漬した状態で、加圧することにより、糠成分を糠から胚乳に浸透移行させ、胚乳に該糠成分を富化し、得られた成分富化籾または成分富化玄米、あるいは、得られた成分富化籾または成分富化玄米を精米してなる成分富化精白米である、前記組成物。 A food or pharmaceutical composition containing high-pressure processed rice as a raw material and for enhancing the effect of suppressing an increase in blood glucose level by interval fast walking training.
The high-pressure processed rice allows the bran component to permeate and transfer from the bran to the endosperm by pressurizing the paddy or brown rice in a state of being immersed in at least 50% by weight of water with respect to the amount of the paddy or brown rice, and the rice is transferred to the endosperm. The composition, which is a component-rich paddy or component-rich brown rice obtained by enriching the bran component, or a component-rich polished rice obtained by milling the obtained component-rich paddy or component-rich brown rice.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017154690 | 2017-08-09 | ||
JP2017154690 | 2017-08-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019030294A JP2019030294A (en) | 2019-02-28 |
JP6847457B2 true JP6847457B2 (en) | 2021-03-24 |
Family
ID=65522499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018150558A Active JP6847457B2 (en) | 2017-08-09 | 2018-08-09 | High-pressure processed rice and food or pharmaceutical compositions containing the high-pressure processed rice |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6847457B2 (en) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100583211B1 (en) * | 1997-08-29 | 2006-05-24 | 더 라이섹스 캄파니, 인코포레이티드 | A method for treating diabetes, hyperglycemia and hypoglycemia |
JP2004000109A (en) * | 2002-05-31 | 2004-01-08 | Junjiro Hasegawa | Hulled rice beverage foodstuff |
JP2005328776A (en) * | 2004-05-20 | 2005-12-02 | National Food Research Institute | Rice for controlling rise of blood glucose level and processed food using the same |
JP2009050193A (en) * | 2007-08-27 | 2009-03-12 | Masamitsu Kawashima | Method for modifying received unpolished rice |
JP4888744B2 (en) * | 2008-08-12 | 2012-02-29 | 国立大学法人信州大学 | Process for enriching grains with polyphenols, foods containing those grains |
JP2013000008A (en) * | 2011-06-13 | 2013-01-07 | Kao Corp | Method for producing processed brown rice |
WO2013015377A1 (en) * | 2011-07-28 | 2013-01-31 | 花王株式会社 | Method for manufacturing processed unpolished rice |
US20150342898A1 (en) * | 2012-12-21 | 2015-12-03 | Advanced Medical Frontier Co., Ltd. | Composition and food or drink |
JP6098973B2 (en) * | 2013-01-22 | 2017-03-22 | 国立大学法人 琉球大学 | Functional food containing γ-oryzanol and anti-diabetes medicine |
US20160196766A1 (en) * | 2013-02-20 | 2016-07-07 | Chistopher Brian Lundin | Weight management method |
JP5651889B1 (en) * | 2013-08-23 | 2015-01-14 | 株式会社かどまさや | Processed brown rice, fermented food, method of manufacturing processed brown rice |
JP2015084658A (en) * | 2013-10-28 | 2015-05-07 | 国立大学法人信州大学 | Ingredient-enriched brown rice and manufacturing method thereof |
-
2018
- 2018-08-09 JP JP2018150558A patent/JP6847457B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2019030294A (en) | 2019-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3231437B1 (en) | Aging inhibitor | |
EP2223697B1 (en) | Lactic acid bacterium-containing preparation | |
TWI745648B (en) | Starter culture containing mixture of lactic acid bacteria strains, and fermented product prepared using such starter culture and use of this fermented product | |
EP3231436B1 (en) | Pharmaceutical composition for prevention or treatment of metabolic disease, comprising bacteroides acidifaciens as effective ingredient | |
TWI737987B (en) | Use of lactic acid bacteria in preparaing a composition for increasing exercise performance and anti-fatigue | |
JP7360420B2 (en) | Grape peels used to treat dysbiosis | |
Castagnini et al. | Reduction of colonic inflammation in HLA-B27 transgenic rats by feeding Marie Ménard apples, rich in polyphenols | |
JP2009142266A (en) | New strain of lactobacillus | |
JP4990352B2 (en) | Drugs effective for allergic diseases and autoimmune diseases | |
EP3861866A1 (en) | Composition comprising molokhia extract as active ingredient for improving gut microbiome or for alleviating, preventing, or treating intestinal inflammation, leaky gut syndrome, obesity, or metabolic disease | |
RU2681791C1 (en) | Biologically active addition of protective action “dreamfood” | |
CN111616353A (en) | Prunus humilis composite fermentation broth for regulating intestinal flora and preparation method thereof | |
CN112190644A (en) | Plant fermentation product, preparation method thereof and application of plant fermentation product in stomach health care | |
JP6847457B2 (en) | High-pressure processed rice and food or pharmaceutical compositions containing the high-pressure processed rice | |
JP4034632B2 (en) | Composition for cooking rice containing lactic acid bacteria | |
EP3443849A1 (en) | Food composition or combination for lowering blood glucose level or reducing gi value | |
CN113797321A (en) | Composition containing mixed grain fermentation enzyme as effective component for preventing or treating weight loss specific metabolic syndrome | |
KR101012346B1 (en) | Extract of Sparassis crispa and Its Use as Anti-inflammatory Medicine | |
RU2621703C2 (en) | Hydroxymethyl furfural derivative | |
US10183052B2 (en) | Mutant tomatoes and use thereof for preventing weight gain and/or treating obesity-related conditions | |
JP7513390B2 (en) | Composition for improving obesity and composition for improving type II diabetes | |
EP2882280B1 (en) | Mutant tomatoes and use thereof for preventing weight gain and/or treating obesity-related conditions | |
JP5284851B2 (en) | Dry brown rice using low amylose rice | |
TWI461206B (en) | Method for producing ferment of glycine max (l.), ferment and uses thereof | |
TWI830123B (en) | Synbiotic composition and uses of synbiotic composition for treating metabolic disorder and improving gut microbial dysbiosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20180906 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191212 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20191212 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20191225 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200129 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200326 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200513 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20200928 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201222 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20201222 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20210108 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20210112 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210128 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210224 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6847457 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |